- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in Netherlands, June 2013
Talk to Robyn
00 1 718 213 49 04
Search inside this page
Publication dates
Publishers
- All
- Business Monitor International
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in Netherlands, June 2013
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
1-28 of about 200 reports
Netherlands Business Projection Industry Update Quarter 2 2012
- $ 1 050
- Industry report
- April 2013
- by Business Monitor International
Includes 3 FREE quarterly updates Core Views The Dutch economy's growth outlook is set to seriously deteriorate in the coming quarters, as the eurozone sovereign debt crisis massively weighs on economic ...
- Industries : Drug and Medication
- Countries : Netherlands
Netherlands Poisonings, 30-44 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012
- $ 1 088
- Industry report
- March 2013
- by Business Monitor International
BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals relative to other Western Europe ...
- Industries : Drug and Medication
- Countries : Netherlands
The Pharmaceutical Market: Netherlands, Business Monitor International
- $ 1 266
- Industry report
- January 2013
- by Business Monitor International
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE NETHERLANDS While the Netherlands is a low-risk market from the point of view ...
- Industries : Drug and Medication
- Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 1 2012
- $ 1 088
- Industry report
- November 2012
- by Business Monitor International
BMI View: The Netherlands boasts a well-developed healthcare system and also an advanced pharmaceutical market, which has attracted significant domestic and foreign investment over the years. Demographic ...
- Industries : Drug and Medication
- Countries : Netherlands
Netherlands Business Forecast Report Q4 2012
- $ 1 050
- Industry report
- October 2012
- by Business Monitor International
Core Views The Dutch economy is set to deteriorate in the coming quarters as the eurozone sovereign debt crisis weighs on economic activity and confidence. While immigration and community cohesion remain ...
- Industries : Drug and Medication
- Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011
- $ 1 088
- Industry report
- August 2012
- by Business Monitor International
BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...
- Industries : Drug and Medication
- Countries : Netherlands
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 3 2012
- $ 985
- Industry report
- May 2012
- by Business Monitor International
Includes 3 FREE quarterly updates BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals ...
- Industries : Prescription Drug
- Countries : Netherlands
Netherlands Pharmaceuticals Industry Update Quarter 2 2009
- $ 1 088
- Industry report
- May 2009
- by Business Monitor International
BMI calculates Netherlands pharmaceutical expenditure to have been Euros 5.90bn (US Dollar 8.68bn) in 2008. By 2013, we expect the total amount spent on prescription and OTC medicines to have reached a ...
- Industries : Pharmaceutical
- Countries : Netherlands
» Download Public Reports
About 200 reports
Netherlands: Brief Outlook, 2012, focus on Pathology
- Country report
- December 2012
- 8 pages
... Mass [13], and in addition, fat distribution may be more important for cardiovascular diseases. However, the question whether wc is more strongly associated with cardiovascular risk than bmi in children ...
Patheon Inc. - Company Report For Year 2012
December 2012Octoplus - Company Report For Year 2012
December 2012The Dutch Pharmaceutical Industry
February 2013Vitamin Sector In China And Netherlands
January 2013Reportlinker.com © Copyright 2013. All rights reserved.
